Cargando…
Histamine Intolerance—The More We Know the Less We Know. A Review
The intake of food may be an initiator of adverse reactions. Food intolerance is an abnormal non-immunological response of the organism to the ingestion of food or its components in a dosage normally tolerated. Despite the fact that food intolerance is spread throughout the world, its diagnosing is...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308327/ https://www.ncbi.nlm.nih.gov/pubmed/34209583 http://dx.doi.org/10.3390/nu13072228 |
_version_ | 1783728254576754688 |
---|---|
author | Hrubisko, Martin Danis, Radoslav Huorka, Martin Wawruch, Martin |
author_facet | Hrubisko, Martin Danis, Radoslav Huorka, Martin Wawruch, Martin |
author_sort | Hrubisko, Martin |
collection | PubMed |
description | The intake of food may be an initiator of adverse reactions. Food intolerance is an abnormal non-immunological response of the organism to the ingestion of food or its components in a dosage normally tolerated. Despite the fact that food intolerance is spread throughout the world, its diagnosing is still difficult. Histamine intolerance (HIT) is the term for that type of food intolerance which includes a set of undesirable reactions as a result of accumulated or ingested histamine. Manifestations may be caused by various pathophysiological mechanisms or a combination of them. The problem with a “diagnosis” of HIT is precisely the inconstancy and variety of the manifestations in the same individual following similar stimuli. The diagnosing of HIT therefore requires a complex time-demanding multidisciplinary approach, including the systematic elimination of disorders with a similar manifestation of symptoms. Among therapeutic approaches, the gold standard is a low-histamine diet. A good response to such a diet is considered to be confirmation of HIT. Alongside the dietary measures, DAO supplementation supporting the degradation of ingested histamine may be considered as subsidiary treatment for individuals with intestinal DAO deficiency. If antihistamines are indicated, the treatment should be conscious and time-limited, while 2nd or 3rd generation of H(1) antihistamines should take precedence. |
format | Online Article Text |
id | pubmed-8308327 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-83083272021-07-25 Histamine Intolerance—The More We Know the Less We Know. A Review Hrubisko, Martin Danis, Radoslav Huorka, Martin Wawruch, Martin Nutrients Review The intake of food may be an initiator of adverse reactions. Food intolerance is an abnormal non-immunological response of the organism to the ingestion of food or its components in a dosage normally tolerated. Despite the fact that food intolerance is spread throughout the world, its diagnosing is still difficult. Histamine intolerance (HIT) is the term for that type of food intolerance which includes a set of undesirable reactions as a result of accumulated or ingested histamine. Manifestations may be caused by various pathophysiological mechanisms or a combination of them. The problem with a “diagnosis” of HIT is precisely the inconstancy and variety of the manifestations in the same individual following similar stimuli. The diagnosing of HIT therefore requires a complex time-demanding multidisciplinary approach, including the systematic elimination of disorders with a similar manifestation of symptoms. Among therapeutic approaches, the gold standard is a low-histamine diet. A good response to such a diet is considered to be confirmation of HIT. Alongside the dietary measures, DAO supplementation supporting the degradation of ingested histamine may be considered as subsidiary treatment for individuals with intestinal DAO deficiency. If antihistamines are indicated, the treatment should be conscious and time-limited, while 2nd or 3rd generation of H(1) antihistamines should take precedence. MDPI 2021-06-29 /pmc/articles/PMC8308327/ /pubmed/34209583 http://dx.doi.org/10.3390/nu13072228 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Hrubisko, Martin Danis, Radoslav Huorka, Martin Wawruch, Martin Histamine Intolerance—The More We Know the Less We Know. A Review |
title | Histamine Intolerance—The More We Know the Less We Know. A Review |
title_full | Histamine Intolerance—The More We Know the Less We Know. A Review |
title_fullStr | Histamine Intolerance—The More We Know the Less We Know. A Review |
title_full_unstemmed | Histamine Intolerance—The More We Know the Less We Know. A Review |
title_short | Histamine Intolerance—The More We Know the Less We Know. A Review |
title_sort | histamine intolerance—the more we know the less we know. a review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8308327/ https://www.ncbi.nlm.nih.gov/pubmed/34209583 http://dx.doi.org/10.3390/nu13072228 |
work_keys_str_mv | AT hrubiskomartin histamineintolerancethemoreweknowthelessweknowareview AT danisradoslav histamineintolerancethemoreweknowthelessweknowareview AT huorkamartin histamineintolerancethemoreweknowthelessweknowareview AT wawruchmartin histamineintolerancethemoreweknowthelessweknowareview |